PHARMACO-ECONOMIC COMPARISON OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION

PHARMACO-ECONOMIC COMPARISON OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION

Acute coronary syndrome (ACS) is a form of coronary heart disease (CHD), combining acute myocardial infarction with ST segment elevation (STE ACS), acute myocardial infarction without ST segment elevation, and unstable angina (non-STE ACS). These clinical forms are considered as one syndrome, due to...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Syrov, S. K. Zyryanov, Yu. B. Belousov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2010-04-01
Series:	Российский кардиологический журнал
Subjects:	acute coronary syndrome anticoagulants therapy costs cost-effectiveness ratio
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1440
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

UTILIZING ENOXAPARIN IN THE MANAGEMENT OF ACUTE CORONARY SYNDROME
by: O. V. Krikunova, et al.
Published: (2018-03-01)

ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?
by: A. L. Komarov, et al.
Published: (2016-01-01)

Comparison of Two Methods of Antepartum Anticoagulation: Continuation of Enoxaparin until Scheduled Induction of Labor Versus Transitioning to Heparin with Spontaneous Labor
by: Marcia DesJardin, et al.
Published: (2024-04-01)

FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME
by: G. V. Mardaryan, et al.
Published: (2015-09-01)

Comparative laboratory effectiveness of low molecular weight heparins in patients with acute coronary syndrome and no ST segment elevation
by: R. M. Linchak, et al.
Published: (2011-02-01)

Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure
by: Alpesh N. Amin, et al.
Published: (2024-02-01)

Antithrombotic Therapy in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary PCI
by: VLAD BATAILA, et al.
Published: (2019-09-01)

2024 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation electrocardiogram
by: O. V. Averkov, et al.
Published: (2025-07-01)

Revascularization of myocardial infarction without ST segment elevation in multivessel coronary artery disease
by: Sh. J. Khalilov, et al.
Published: (2024-10-01)

Cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism
by: Isabel Elías, et al.
Published: (2016-05-01)

Optimising the treatment of patients with acute coronary syndrome without ST segment elevation
by: T. M. Poponina, et al.
Published: (1970-01-01)

2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation
by: O. L. Barbarash, et al.
Published: (2021-05-01)

Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-11-01)

THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017-01-01)

THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY
by: O. V. Reshetko, et al.
Published: (2016-01-01)

SOCIO-ECONOMIC DAMAGE BY ACUTE CORONARY SYNDROME IN RUSSIAN FEDERATION
by: A. V. Kontsevaya, et al.
Published: (2016-01-01)

CLINICAL TREATMENT FOR ANTERIOR DESCENDING ARTERY THROMBOSIS IN A PATIENT WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION
by: V. V. Efimov, et al.
Published: (2019-02-01)

FONDAPARINUX IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION – JUSTIFICATION FOR USING AND REAL CLINICAL PRACTICE
by: A. D. Erlikh
Published: (2018-05-01)

Antiaggregant influence on platelet aggregation in patients with acute coronary syndrome without ST segment elevation
by: T. M. Poponina, et al.
Published: (2006-10-01)

Coronary Artery Lesions during Coronary Angiography in Acute ST-Segment Elevation Myocardial Infarction with and without Reciprocal Changes
by: Ibrahim Bilal Wahhab, et al.
Published: (2023-04-01)

Safety and efficacy of post-procedure anticoagulation in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary percutaneous coronary intervention
by: Can Zhou, et al.
Published: (2025-03-01)

Improvement of the efficiency of treatment in patients with coronary artery disease and metabolic syndrome after percutaneous coronary intervention for acute coronary syndrome without ST-segment elevation.
by: N. V. Chumachenko
Published: (2016-05-01)

REPERFUSION THERAPY IN ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION
by: A. L. Alyavi, et al.
Published: (2016-01-01)

EARLY DISCONTINUATION OF FONDAPARINUX IN LOW-RISK PATIENTS HOSPITALIZED WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME: MARKERS OF HEMOSTASIS ACTIVATION AND IN-HOSPITAL OUTCOMES
by: I. S. Yavelov, et al.
Published: (2015-03-01)

Reassess Hospital Costs and Mortality Between Myocardial Infarction With and Without ST‐Segment Elevation in a Modern Context
by: Honglan Ma, et al.
Published: (2024-11-01)

ANTICOAGULANTS IN ACUTE CORONARY SYNDROME
by: I. A. Latfullin, et al.
Published: (2016-01-01)

Cardiometabolic risk factors in predicting obstructive coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome
by: B. I. Geltser, et al.
Published: (2021-12-01)

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
by: O. V. Averkov
Published: (2012-06-01)

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
by: . .
Published: (2016-03-01)

Percutaneous Coronary Intervention with Procedural Unfractionated Heparin without Activated Clotting Time Guidance: A Unique Opportunity to Assess Thrombotic and Bleeding Events
by: Ali Z. Zgheib, et al.
Published: (2024-01-01)

Results of coronary bypass surgery performed in the early stages of non-ST segment elevation acute coronary syndrome
by: Yu. V. Neverova, et al.
Published: (2019-09-01)

Rivaroxaban vs. enoxaparin for preventing venous thromboembolism after hip fracture operations: a retrospective cohort study
by: Xiaofeng Zheng, et al.
Published: (2025-05-01)

Economic Impact of Surveillance of Head Trauma Patients with Coagulopathy and Normal Initial Computed Tomography Scan (ECO-NCT)
by: Tiago Ribeiro da Costa, et al.
Published: (2025-01-01)

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
by: J.-P. Collet, et al.
Published: (2021-04-01)

ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION
by: D. H. Ainetdinova, et al.
Published: (2016-01-01)

Contrast-induced nephropathy in patients with acute coronary syndrome with ST-segment elevation: risk factors and prognosis
by: O. V. Arsenicheva, et al.
Published: (2020-01-01)

Features of metabolic correction in patients after percutaneous coronary intervention for acute coronary syndrome without ST elevation
by: L.S. Kholopov, et al.
Published: (2016-03-01)

Cost-effectiveness and budget impact analysis of rivaroxaban with or without aspirin compared to aspirin alone in patients with coronary and peripheral artery diseases in Iran
by: Zahra Goudarzi, et al.
Published: (2025-03-01)

Paradoxes of non-ST-segment elevation acute coronary in real-life clinical practice settings
by: A. K. Nesova, et al.
Published: (2024-04-01)

DEATH CAUSES AND THEIR PREDICTION IN PATIENTS WITH THE ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME AND PRE-HOSPITAL THROMBOLYSIS
by: S. N. Morozov, et al.
Published: (2013-04-01)